Wells Fargo Starts Omnicom Group (OMC) at Market Perform; Capital Return Accelerating, but Expectations Running High
Get Alerts OMC Hot Sheet
Price: $86.93 -0.57%
Rating Summary:
8 Buy, 19 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Rating Summary:
8 Buy, 19 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 9 | Down: 12 | New: 19
Join SI Premium – FREE
Wells Fargo initiates coverage on Omnicom Group (NYSE: OMC) with a Market Perform. Valuation range of $50-51.
Wells analyst says, "In our view, a premium collection of global agency assets and high expectations for capital returns support group-leading multiples that exceed the company's historical relationship with the S&P 500. Rolling off of the mega Chrysler loss should boost OMC's near-term growth; we expect longer-term growth to be in line with peers' as the company seeks additional emerging market exposure. We estimate $3.32 and $3.79 EPS in 2011 and 2012, repectively, against consensus estimates of $3.23 and $3.71."
For more ratings news on Omnicom Group click here and for the rating history of Omnicom Group click here.
Shares of Omnicom Group closed at $47.88 yesterday.
Wells analyst says, "In our view, a premium collection of global agency assets and high expectations for capital returns support group-leading multiples that exceed the company's historical relationship with the S&P 500. Rolling off of the mega Chrysler loss should boost OMC's near-term growth; we expect longer-term growth to be in line with peers' as the company seeks additional emerging market exposure. We estimate $3.32 and $3.79 EPS in 2011 and 2012, repectively, against consensus estimates of $3.23 and $3.71."
For more ratings news on Omnicom Group click here and for the rating history of Omnicom Group click here.
Shares of Omnicom Group closed at $47.88 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wells Fargo Starts Progyny (PGNY) at Overweight
- Jefferies Starts Anthem Biosciences (ANTHEM:IN) at Buy
- Canaccord Starts Incyte (INCY) at Buy
Create E-mail Alert Related Categories
New CoverageRelated Entities
Chrysler LLC, Wells FargoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share